Efinopegdutide

DB15077Investigational

Efinopegdutide is under investigation in clinical trial NCT03606057 (A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough...

Mechanism: Pharmacologically active on Glucagon receptor and Glucagon-like peptide 1 receptor
Curator reviewed
Also known as: JNJ-64565111
Code names: HM12525A · MK-6024

Resolves to

Compound

UNIIDR6P1M58POCAS2055640-93-0

Targets

P47871GCGRP43220GLP1R

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

14Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Efinopegdutide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account